NORWOOD, Mass., May 12, 2022 – PRESS RELEASE – MariMed Inc., a leading multistate cannabis operator focused on improving lives every day, announced the appointment of Jon Levine to the new role of chief administration officer (CAO) and the appointment of Susan Villare to chief financial officer (CFO) effective May 12, 2022. Strengthening MariMed’s leadership team will enable the company to more effectively implement its strategic growth plan and solidify MariMed’s status as a premier national cannabis company.
Levine co-founded MariMed with CEO Bob Fireman. As the company’s CFO, he drove the financial discipline required to make MariMed an industry leader. The company’s finance and accounting teams, operations, sales and marketing, and external communications will all now report to Levine as CAO.
Villare is a CPA and finance executive with nearly 30 years of experience leading global and national organizations through transformations and dynamic growth. Most recently, Villare was the senior vice president of Financial Planning and Analysis and treasurer for Ribbon Communications and held CFO and other senior finance leadership positions for public and private companies, including BigBand Networks, Burst Media, MatrixOne, and Price Waterhouse. She has an accounting degree from Boston College and is skilled in the areas of financial reporting and analysis, mergers and acquisitions, ERP implementations, investor relations and more.
"Jon has been a driving force behind MariMed’s success the past decade, including positioning us financially to achieve our ambitious growth goals,” Fireman said. “As CAO, and with Susan, a seasoned finance executive in place, Jon can now assume a greater role to use his decade of cannabis management and operation experience to help lead MariMed into the next phase of our promising future.”Levine said, “I am excited to embark on this expanded role at MariMed, which is possible in large part because we are welcoming such a talented executive to take on our CFO role. Susan’s experience managing and analyzing complex financial and accounting data, and negotiating and integrating dozens of acquisitions in high-growth industries, will be invaluable as MariMed embarks on the next phase of its growth strategy.”